Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: J Adolesc Health. 2020 Aug 11;68(3):488–496. doi: 10.1016/j.jadohealth.2020.06.041

Table 3.

Scenario set 2: simulated HIV epidemic outcomes assuming pre-exposure prophylaxis (PrEP) adherence and retention profiles among adolescent sexual minority males (ASMM) from the ATN113 trial with retention averaged across the study duration

Scenarios Uptake Incidence (95% SI) NIA/100K
person-years
at risk (95% SI)
PIA (95% SI) PrEP coverage
among all sexually
active ASMM
(95% SI)
NNT (95% SI) Prevalence among
18-year-old ASMM
after 10 years
(95% SI)
No PrEP NA 1,191 (1,090, 1,276) NA NA NA 5.8 (4.3, 7.6)
Control .1 1,153 (1,055, 1,252) 57 (−183, 307) 2.8 (−11.0, 15.8) 4.5 (4.4, 4.7) 40.2 (−267.2, 603.5) 5.4 (4.2, 6.8)
Intervention 1,141 (1,061, 1,220) 74 (−189, 297) 3.8 (−11.4, 15.4) 4.5 (4.4, 4.7) 48.8 (−410.3, 351.8) 5.3 (4.2, 6.6)
Control .25 1,098 (999, 1,198) 139 (−100, 382) 7.4 (−5.8, 19.7) 11.0 (10.8, 11.2) 96.7 (−307.4, 610.8) 5.1 (4.0, 6.3)
Intervention 1,032 (951, 1,110) 240 (−27, 460) 13.0 (−1.6, 24.1) 11.0 (10.9,11.2) 69.9 (−250.4, 387.7) 4.7 (3.7, 5.7)
Control .5 1,028 (928, 1,103) 246 (−6, 437) 13.4 (−.4, 23.1) 20.7 (20.5, 21.0) 128.8 (73.8, 446.8) 4.8 (3.6, 5.9)
Intervention 905 (825, 1,000) 431 (198, 670) 23.7 (12.2, 34.8) 20.8 (20.6, 21.0) 75.9 (52.1, 130.6) 4.2 (2.9, 5.5)
Control .75 955 (858, 1,037) 356.(100, 606) 19.5 (6.0, 31.3) 29.3 (29.1, 29.6) 131 (77.1, 295.6) 4.3 (3.0, 5.7)
Intervention 800 (727, 877) 590 (395,81) 32.6 (23.9, 41.7) 29.4 (29.2, 29.7) 75.6 (59, 103.3) 3.5 (2.6, 4.4)
Control 1 895 (819, 984) 447 (222, 640) 24.6 (13.3, 33.8) 36.8 (36.5, 37.1) 126.8 (92.6, 217.8) 4.1 (3.1, 5.3)
Intervention 716 (643, 789) 715 (501, 911) 39.6 (29.8, 48.2) 36.9 (36.7, 37.2) 78.1 (63.2, 104) 3.2 (2.3, 4.1)

NIA = number of infections averted; NNT = number needed to treat to avert a single infection; PIA = percent of infections averted; SI = simulation interval.